AAEE case report #16: Botulism
- 1 December 1988
- journal article
- case report
- Published by Wiley in Muscle & Nerve
- Vol. 11 (12) , 1201-1205
- https://doi.org/10.1002/mus.880111203
Abstract
Botulinal toxin causes a marked reduction in the number of quanta released by autonomic and motor nerve terminals. As a result it causes blurred vision, inability to move the eyes, weakness of other cranial nerve‐innervated muscles, dyspnea progressing to apnea, and generalized weakness. Electrodiagnostic findings in severe botulism can be relatively nonspecific, with low amplitude and short duration motor unit action potentials and small M wave amplitudes. A modest increment in M wave amplitude with rapid repetitive nerve stimulation may help to localize the disorder to the neuromuscular junction. Identification of the toxin in the patient's serum is diagnostic. The treatment of botulism is mainly supportive.Keywords
This publication has 20 references indexed in Scilit:
- Aminoglycosides and 3, 4‐diaminopyridine on neuromuscular block caused by botulinum type a toxinMuscle & Nerve, 1987
- Infant Botulism in AdultsNew England Journal of Medicine, 1986
- Clinical electrophysiology of infantile botulismMuscle & Nerve, 1983
- Single fibre EMG in 6 cases of botulismActa Neurologica Scandinavica, 1983
- Tick Paralysis With Persistent Weakness and Electromyographic AbnormalitiesArchives of Neurology, 1981
- Disorders of Neuromuscular Transmission Caused by DrugsNew England Journal of Medicine, 1979
- Botulism and guanidine. Ten years laterJAMA, 1978
- Human Botulism Studied With Single-Fiber ElectromyographyArchives of Neurology, 1978
- Pathophysiologic Aspects of Human BotulismArchives of Neurology, 1976
- Wound botulism. A case reportPublished by American Medical Association (AMA) ,1974